Smith & Nephew Share Price | |
---|---|
Price | 964.40 |
Bid | 961.20 |
Ask | 961.60 |
Change | -19.00 (-1.93%) |
Volume | 4,362,121 |
Open | 982.60 |
High | 987.40 |
Low | 960.60 |
Prev. Close | 983.40 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 874.33m |
Market Capitalisation | £8.43b |
Market Size | 2,000 |
52 Week High | 1,316.00 |
52 Week High Date | 02-May-2023 |
52 Week Low | 887.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 5,722 |
---|---|
Vol. Sold | 676,925 |
Sold Value | £6.22m |
Vol. Bought | 2,324,712 |
Bought Value | £22.25m |
PE Ratio | 40.6579 |
Earnings | 23.71987 |
Dividend | 30.27 |
Yield | 3.139% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
25-Apr-24 | 18:09:37 | 980.119 | 5,203 | Unknown* | 961.20 | 961.60 | 51.00k | O Ordinary Was reported as OTC |
25-Apr-24 | 18:09:01 | 964.068 | 16,896 | Unknown* | 961.20 | 961.60 | 162.89k | O Ordinary Was reported as OTC |
25-Apr-24 | 18:08:28 | 980.711 | 16,964 | Unknown* | 961.20 | 961.60 | 166.37k | O Ordinary Was reported as OTC |
25-Apr-24 | 18:07:04 | 966.598 | 64,870 | Unknown* | 961.20 | 961.60 | 627.03k | O Ordinary Was reported as OTC |
25-Apr-24 | 17:58:43 | 964.40 | 443,270 | Unknown* | 961.20 | 961.60 | 4m | O Ordinary Was reported as OTC |
25-Apr-24 | 17:58:05 | 980.558 | 17,655 | Unknown* | 961.20 | 961.60 | 173.12k | O Ordinary Was reported as OTC |
25-Apr-24 | 17:55:37 | 964.40 | 463 | Unknown* | 961.20 | 961.60 | 4,465 | O Ordinary Was reported as OTC |
25-Apr-24 | 17:55:37 | 964.40 | 769 | Unknown* | 961.20 | 961.60 | 7,416 | O Ordinary Was reported as OTC |
25-Apr-24 | 17:55:10 | 964.40 | 67 | Unknown* | 961.20 | 961.60 | 646.15 | O Ordinary Was reported as OTC |
25-Apr-24 | 17:55:10 | 964.40 | 3,355 | Unknown* | 961.20 | 961.60 | 32.36k | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
17-Jan-24 | 09-Jan-24 | Buy | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 23.19 | USD | 408 | 107,222 |
14-Nov-23 | 13-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 1,001.09 | GBX | 1,961 | 106,814 |
14-Nov-23 | 13-Nov-23 | Transfer From | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 0.00 | 4,788 | 106,814 | |
10-Nov-23 | 10-Nov-23 | Buy | Jeremy (Jez) Maiden held the position of Independent Non-Executive Director at the time of this trade.Jeremy (Jez) Maiden | 1,007.75 | GBX | 1,000 | 1,000 |
10-Nov-23 | 08-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 987.80 | GBX | 1,771 | 103,987 |
Smith+Nephew is a portfolio medical device company focused on the repair, regeneration and replacement of soft and hard tissue.